The preparation of
protein–protein, protein–peptide,
and protein–small molecule conjugates is important for a variety
of applications, such as vaccine production, immunotherapies, preparation
of antibody–drug conjugates, and targeted delivery of therapeutics.
To achieve site-selective conjugation, selective chemical or enzymatic
functionalization of proteins is required. We have recently reported
biosynthetic pathways in which small, catalytic scaffold peptides
are utilized for the generation of amino acid-derived natural products
called pearlins. In these systems, peptide amino-acyl tRNA ligases
(PEARLs) append amino acids to the C-terminus of a scaffold peptide,
and tailoring enzymes encoded in the biosynthetic gene clusters modify
the PEARL-appended amino acid to generate a variety of natural products.
Herein, we investigate the substrate selectivity of one such tailoring
enzyme, BhaC
1
, that participates in pyrroloiminoquinone
biosynthesis. BhaC
1
converts the indole of a C-terminal
tryptophan into an
o
-hydroxy-
p
-quinone,
a promising moiety for site-selective bioconjugation. Our studies
demonstrate that BhaC
1
requires a 20-amino acid peptide
for substrate recognition. When this peptide was appended at the C-terminus
of proteins, the C-terminal Trp was modified by BhaC
1
.
The enzyme is sufficiently selective that only small changes to the
sequence of the peptide are tolerated. An AlphaFold model for substrate
recognition explains the selectivity of the enzyme, which may be used
to install a reactive handle onto the C-terminus of proteins.